MODEL-AD
Generating and characterizing mouse models of late-onset Alzheimer’s disease to improve AD target discovery and validation
The MODEL-AD (Model Organism Development and Evaluation for Late-Onset Alzheimer’s Disease) consortium is a group of researchers focused on rigorous generation and characterization of fifty new mouse models of late-onset Alzheimer’s disease. Alzheimer’s disease (AD) is a debilitating illness with no known disease-modifying therapy. Furthermore, 99.3% of phase III clinical trials have failed for AD drug discovery.
The goal of the MODEL-AD consortium is to improve target discovery and validation efforts in AD by creating a community resource of mouse models that closely reflect the sporadic late-onset human form of AD. The group has focused on human AD genetics and systems biology resources such as Accelerating Medicine Partnership for AD (AMP-AD), AD Sequencing Project (ADSP), and AD Neuroimaging Initiative (ADNI) to prioritize specific variants to introduce into the mice to capture different aspects of the disease. All data – including ‘omics, imaging, and drug treatment – generated on the mouse models are actively distributed to the AD research community and public via the AD Knowledge Portal.
More Scientific Coordination Projects
imCORE Network Data Repository
Sage Bionetworks will serve as a data coordinating center to manage, curate, and disseminate the data and resources generated through the imCORE Network
Learn MoreTREAT-AD
TREAT-AD’s mission is to address the urgent need for therapies to effectively treat or prevent Alzheimer’s disease
Learn MorePsychENCODE Consortium
A collaboration to provide an enhanced framework of regulatory genomic elements in individuals with neuropsychiatric disorders
Learn More